Eben Massari, Ph.D. has a successful track record in small molecule drug discovery with more than 20 years’ experience in the biotech industry. He joined as an Advisor to the Accelerator in 2020 and currently serves as Sr. Vice President of Biology at Nerio Therapeutics. Previously, Dr. Massari was Vice President of Screening and CNS Discovery with Plexium. He also served as Director of Lead Discovery at Dart Neuroscience where he was a project leader for the PDE2 inhibitor program that advanced two molecules into the clinic for cognitive impairment associated with schizophrenia and stroke rehabilitation. Prior to his time at Dart, Dr. Massari was Investigator and Head of Screening at Kalypsys. Dr. Massari was also a Sr. Research Biologist at Merck Research Laboratories where his work contributed to programs for pain, stroke, and new technology development. He is a co-author of 24 publications and co-inventor on multiple patents.

Dr. Massari completed his postdoctoral training at the University of California, San Diego. He earned his Ph.D. in Biology from the University of California, San Diego and his B.A. in Biology from the University of California, Santa Cruz.